Financial insights of SXTPW

MyFinsight

For the quarter ending 2026-03-31, SXTPW made $162,092 in revenue. -$2,089,214 in net income. Net profit margin of -1288.91%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Product revenues net of discounts and rebates	162,092	197,670*	437,602	100,932
Cost of revenues	85,715	-99,916.5*	537,690	50,051
Gross profit	76,377	297,586.5*	-100,088	50,881
Research revenues	0	-43,224.5*	90,960	206,939
Net revenue	76,377	254,362*	-9,128	257,820
Research and development	281,464	516,664.5*	809,777	249,884
General and administrative expenses	1,889,874	1,128,262*	1,506,620	1,612,764
Total operating expenses	2,171,338	1,644,926.5*	2,316,397	1,862,648
Loss from operations	-2,094,961	-1,390,564.5*	-2,325,525	-1,604,828
Interest expense	1,389	3,411.5*	1,708	1,221
Change in fair value of derivative liabilities	4,567	23,764*	21,103	140,447
Other income, net	10,762	77,211*	31,550	13,066
Total interest and other income (expense), net	-	97,563.5*	-	-
Total interest and other income, net	4,806	-	8,739	-128,602
Loss from operations before provision for income taxes	-2,090,155	-1,293,001*	-2,316,786	-1,733,430
Provision for income taxes (note 9)	0	-2,625*	250	1,500
Net loss	-2,090,155	-1,290,376*	-2,317,036	-1,734,930
Net loss noncontrolling interest	-941	-293*	-712	-1,204
Net loss attributed to 60 degrees pharmaceuticals, inc	-2,089,214	-1,290,083	-2,316,324	-1,733,726

Basic EPS	-1.28	-1.925	-0.66	-1.25
Diluted EPS	-1.28	-1.925	-0.66	-1.25
Basic Average Shares	1,725,758	670,211*	3,675,407	1,472,891
Diluted Average Shares	1,725,758	670,211*	3,675,407	1,472,891